Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

The clinical effects of the oral beta 1 partial agonist, prenalterol, were investigated in 37 patients (29 male, eight female; mean age 57 years) with chronic ischaemic left ventricular failure using a placebo controlled randomised double blind protocol over six months. All patients were limited by...

Celý popis

Podrobná bibliografie

Vydáno v:	Br Heart J
Hlavní autoři:	Glover, D R, Wathen, C G, Murray, R G, Petch, M C, Muir, A L, Littler, W A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1985
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481741/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2857088/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.2.208
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!